Literature DB >> 31701439

Injury-Induced Effectors of Neuropathic Pain.

Damien P Kuffler1.   

Abstract

Injuries typically result in the development of neuropathic pain, which decreases in parallel with wound healing. However, the pain may remain after the injury appears to have healed, which is generally associated with an ongoing underlying pro-inflammatory state. Injury induces many cells to release factors that contribute to the development of a pro-inflammatory state, which is considered an essential first step towards wound healing. However, pain elimination requires a transition of the injury site from pro- to anti-inflammatory. Therefore, developing techniques that eliminate chronic pain require an understanding of the cells resident at and recruited to injury sites, the factors they release, that promote a pro-inflammatory state, and promote the subsequent transition of that site to be anti-inflammatory. Although a relatively large number of cells, factors, and gene expression changes are involved in these processes, it may be possible to control a relatively small number of them leading to the reduction and elimination of chronic neuropathic pain. This first of two papers examines the roles of the most salient cells and mediators associated with the development and maintenance of chronic neuropathic pain. The following paper examines the cells and mediators involved in reducing and eliminating chronic neuropathic pain.

Entities:  

Keywords:  Cytokines; Inflammation; Nerve injury; Pro-inflammatory mediators; Voltage-gated ion channels

Year:  2019        PMID: 31701439     DOI: 10.1007/s12035-019-01756-w

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  2 in total

1.  Mesenchymal stem cell spheroids alleviate neuropathic pain by modulating chronic inflammatory response genes.

Authors:  Nayeon Lee; Gyu Tae Park; Jae Kyung Lim; Eun Bae Choi; Hye Ji Moon; Dae Kyoung Kim; Seong Min Choi; Young Cheol Song; Tae Kyun Kim; Jae Ho Kim
Journal:  Front Immunol       Date:  2022-08-08       Impact factor: 8.786

Review 2.  Lysophosphatidylcholine: Potential Target for the Treatment of Chronic Pain.

Authors:  Jinxuan Ren; Jiaqi Lin; Lina Yu; Min Yan
Journal:  Int J Mol Sci       Date:  2022-07-27       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.